Pregled bibliografske jedinice broj: 773683
Genes involved in maintaining the bone marrow stroma are dysregulated in patients with myelofibrosis: Lenalidomide treatment up-regulates SOCS3
Genes involved in maintaining the bone marrow stroma are dysregulated in patients with myelofibrosis: Lenalidomide treatment up-regulates SOCS3 // Anticancer research, 35 (2015), 10; 5221-5223 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 773683 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Genes involved in maintaining the bone marrow stroma are dysregulated in patients with myelofibrosis: Lenalidomide treatment up-regulates SOCS3
Autori
Livun, Ana ; Newberry, Kate ; Manshouri, Taghi ; Kušec, Rajko ; Verstovšek, Srđan
Izvornik
Anticancer research (0250-7005) 35
(2015), 10;
5221-5223
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
SOCS3; primary myelofibrosis; lenalidomide
Sažetak
The purpose of our study was to determine whether genes involved in the organisation of the stem cell nice were dysregulated in patients with primary myelofibrosis. Our finding suggests that treatment with lenalidomide plus prednisone up-regulates SOCS3 while several other genes show aberrant expression.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1980955-3094 - Genetika i funkcija hematopoeze i mikrookoliša Ph- mijeloproliferativnih bolesti (Kušec, Rajko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
